EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From laboratory to point of care: Clinical performance and validation of bSens.INR for prothrombin time and INR monitoring

Julia Konzen Moreira, Gabriela Victória de Mello Jantzch, Duane da Silva Moraes, Bruna Ferri Serafini, Milleny Germann Souza, Marcele Arais Hocevar, Rodrigo Ritzel Bernasconi, Fernanda Santos Dos Santos, Willyan Hasenkamp Carreira

Practical Laboratory Medicine · 2026-12 · 52 · e00564

DOI: 10.1016/j.plabm.2026.e00564 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Practical Laboratory Medicine, 2026-12. Verfasst von Julia Konzen Moreira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Chemistry, Federal University of Rio Grande do Sul, 91501-970, Brazil. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CNPq, CAPES, Finep.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anticoagulant therapy with vitamin K antagonists, particularly warfarin, requires periodic monitoring of prothrombin time (PT) and the International Normalized Ratio (INR) to maintain patients within the therapeutic range and reduce thromboembolic and hemorrhagic risks. Point-of-care (POC) devices may improve the accessibility and frequency of anticoagulation monitoring.

Objectives

To evaluate the clinical performance of bSens.INR, a POC system for quantitative PT/INR determination, by comparison with a laboratory reference method and assessment of precision and usability. Patients/methods: Clinical validation included 77 participants and 200 capillary blood determinations performed in duplicate (400 bSens.INR tests), with corresponding venous samples analyzed by laboratory reference methods. Accuracy, repeatability, intermediate precision, and usability were assessed. Potential interfering factors were evaluated descriptively and exploratorily.

Results

Overall, 98,5% of results met the predefined accuracy acceptance criteria, demonstrating adequate agreement with the laboratory reference method. Accuracy decreased at INR values above 3.7. All duplicate measurements met the repeatability acceptance criteria, with variability below 10%. Intermediate precision and usability assessments further supported system performance under the evaluated conditions. Exploratory assessment of potential interfering factors did not establish causal relationships but identified factors warranting further investigation. Conclusions: bSens.INR demonstrated adequate clinical performance for PT/INR determination under the evaluated conditions. These findings provide clinical evidence supporting its regulatory evaluation by the Brazilian Health Regulatory Agency (ANVISA). Further studies should investigate higher INR ranges, potential interfering factors, and real-world performance, including self-monitoring.

Schlagwörter

Stichwörter der Autor:innen

AnticoagulationClinical validationInternational normalized ratioMonitoringPoint-of-careProthrombin timeWarfarin

Autor:innen und Institutionen

  • Postgraduate Program in Chemistry, Federal University of Rio Grande do Sul, 91501-970, Brazil.
  • Biosens Biosensor Development and Manufacturing Ltda., 93022-715, Brazil.
  • Postgraduate Program in Environmental Quality, Feevale University, 93525-075, Brazil.
  • Postgraduate Program in Mining, Metallurgical and Materials Engineering, Federal University of Rio Grande do Sul, 91501-970, Brazil.
  • Postgraduate Program of Collective Health, University of Vale do Rio dos Sinos, 93022-750, Brazil.
  • Undergraduate Program in Systems Analysis and Development, University of Vale do Rio dos Sinos, 93022-750, Brazil.

Förderung

  • CNPq
  • CAPES
  • Finep

Zitieren

APA

Moreira, J. K., de Mello Jantzch, G. V., da Silva Moraes, D., Serafini, B. F., Souza, M. G., Hocevar, M. A., Bernasconi, R. R., Dos Santos, F. S., & Carreira, W. H. (2026). From laboratory to point of care: Clinical performance and validation of bSens.INR for prothrombin time and INR monitoring. Practical Laboratory Medicine, 52, e00564. https://doi.org/10.1016/j.plabm.2026.e00564

Vancouver

Moreira JK, de Mello Jantzch GV, da Silva Moraes D, Serafini BF, Souza MG, Hocevar MA, et al. From laboratory to point of care: Clinical performance and validation of bSens.INR for prothrombin time and INR monitoring. Practical Laboratory Medicine. 2026;52:e00564. doi:10.1016/j.plabm.2026.e00564

BibTeX
@article{Moreira2026,
  author = {Moreira, Julia Konzen and de Mello Jantzch, Gabriela Victória and da Silva Moraes, Duane and Serafini, Bruna Ferri and Souza, Milleny Germann and Hocevar, Marcele Arais and Bernasconi, Rodrigo Ritzel and Dos Santos, Fernanda Santos and Carreira, Willyan Hasenkamp},
  title = {From laboratory to point of care: Clinical performance and validation of bSens.INR for prothrombin time and INR monitoring},
  journal = {Practical Laboratory Medicine},
  year = {2026},
  volume = {52},
  pages = {e00564},
  doi = {10.1016/j.plabm.2026.e00564}
}
Kostenlos starten →